Medline Inc. (MDLN) stock
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3066% above fair value
$39.47−0.51 (-1.28%)
Close on Nov 13, 2026Market cap $51.89BP/E –Yield –
Medline cash
Cash and short-term investments held at the end of each period.
Medline's cash was $3.61B at Sep 26, 2026. For fiscal 2025 it was $1.94B, up 675.6% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.94B | +675.6% |
| FY2024 | Dec 31, 2024 | $250.00M | -84.2% |
| FY2023 | Dec 31, 2023 | $1.59B | +297.2% |
| FY2022 | Dec 31, 2022 | $399.00M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $3.61B | +277.8% |
| Q2 FY2026 | Jun 27, 2026 | $2.68B | +358.4% |
| Q1 FY2026 | Mar 28, 2026 | $2.24B | +166.2% |
| Q4 FY2025 | Dec 31, 2025 | $1.94B | +675.6% |
| Q3 FY2025 | Sep 27, 2025 | $955.00M | -39.7% |
| Q2 FY2025 | Jun 28, 2025 | $584.00M | +46.4% |
| Q1 FY2025 | Mar 29, 2025 | $840.00M | – |
| Q4 FY2024 | Dec 31, 2024 | $250.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.59B | – |
| Q4 FY2022 | Dec 31, 2022 | $399.00M | – |
See a number that looks wrong?